GRIGUOLO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 54
EU - Europa 10
AS - Asia 6
OC - Oceania 1
Totale 71
Nazione #
US - Stati Uniti d'America 53
CN - Cina 3
FI - Finlandia 3
IE - Irlanda 2
IT - Italia 2
UA - Ucraina 2
VN - Vietnam 2
AU - Australia 1
CA - Canada 1
DE - Germania 1
IN - India 1
Totale 71
Città #
Fairfield 10
Seattle 7
Houston 4
Ashburn 3
Beijing 3
Wilmington 3
Woodbridge 3
Dong Ket 2
Dublin 2
Helsinki 2
Princeton 2
Ann Arbor 1
Boardman 1
Buffalo 1
Cambridge 1
Fiesole 1
Hyderabad 1
Lappeenranta 1
Montreal 1
Munich 1
Norwalk 1
Redmond 1
San Diego 1
Santa Clara 1
Sydney 1
Totale 55
Nome #
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 55
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 12
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 12
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 7
Totale 86
Categoria #
all - tutte 640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 6 4 8 5 3 0
2020/202118 1 3 1 1 1 1 0 4 0 2 0 4
2021/202216 0 3 0 0 0 0 1 0 1 1 8 2
2022/20237 2 0 0 0 0 2 0 0 3 0 0 0
2023/202416 1 0 0 1 3 0 1 0 0 3 4 3
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 86